Structure Activity Relationship (SAR) Explained | Medicinal Chemistry

Added:

Systems Pharmacology and Phenotypic Drug Discovery

Traditional Structure-Activity Relationship (SAR) is fundamentally reductionist, operating on the 'one drug, one target' model to optimize potency against a single biological receptor. However, critics argue this target-centric SAR often fails in clinical trials due to biological complexity, compensatory pathways, and off-target toxicities. Systems Pharmacology and Phenotypic Drug Discovery (PDD) offer a powerful counter-perspective. Instead of optimizing a molecule for a single isolated target, PDD evaluates compounds based on their holistic effects on cellular systems or whole organisms without requiring prior target knowledge. This paradigm recognizes that therapeutic efficacy is often the result of polypharmacology—weak, synergistic interactions with multiple targets rather than high-affinity binding to one. Furthermore, the phenomenon of 'activity cliffs'—where trivial structural modifications cause unpredictable, catastrophic changes in activity—challenges the assumption of predictable, linear SAR. This alternative approach shifts the focus from narrow molecular-level optimization to system-wide therapeutic outcomes.

Basic organic chemistry, specifically recognizing common functional groups (e.g., esters, amides, hydroxyls, halogens) and their polarities.
Fundamental concepts of drug-receptor interactions, including key intermolecular forces such as hydrogen bonding, ionic interactions, and van der Waals forces.
The concept of biological potency, efficacy, and basic pharmacological definitions (e.g., IC50, EC50, Kd).
General biochemistry principles regarding protein structure and active binding sites of enzymes and receptors.
Quantitative Structure-Activity Relationship (QSAR) modeling, which uses mathematical methods to predict biological activity based on physical properties.
Bioisosteric replacement strategies to modify functional groups to improve drug efficacy or reduce toxicity while maintaining biological activity.
Optimizing ADME (Absorption, Distribution, Metabolism, and Excretion) properties alongside potency during lead optimization.
In silico (computer-aided) molecular docking and virtual screening to predict structure-activity relationships computationally.
11.1K views193likes38:27@RFQ-09-18Original Release: 2022-07-28

Structure-Activity Relationship (SAR) is the fundamental principle in medicinal chemistry that examines how modifications to a drug molecule's chemical structure affect its biological activity, enabling scientists to predict and optimize drug efficacy and safety through strategic functional group modifications such as changing molecular size/shape, degree of unsaturation, introducing new substituents, or altering ring systems.